TRPM7 and myocardial infarction: Such TRPM7-mediated profibrotic effects occur in cardiac disease conditions such as myocardial infarction (Li et al., 2008), atrial fibrillation (Du et al., 2010), and sick sinus syndrome (Zhong H. et al., 2018) as well as following receptor-mediated cardiac stimulation with agonists like angiotensin II (Yu Y. et al., 2014; Zhou et al., 2015; Li et al., 2017; Zhong H. et al., 2018) and isoprenaline (Li et al., 2017; Wu et al., 2018).